Oglionucleotide Cards
Responses closed . Full description on SAM.gov.
Overview
- Response deadline
- 7:00 AM PDT
- Posted
- June 22, 2026
- Notice type
- Special Notice
- Set-aside
- No Set aside used
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of WarDepartment of the Navy
Notice details
- Office
- ONR.ONR NRL.NAVAL RESEARCH LABORATORY
- Place of performance
- Washington, District of Columbia, 20375
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- N0017326Q5252
- Notice ID
- aa6db2acf9f942c3853a5c9206302a84
Description
NOTICE OF INTENT TO AWARD A SOLE SOURCE
This Notice of Intent is not a request for competitive proposals. This is not a solicitation or request for offers. Only one responsible source and no other supplies or services will satisfy agency requirements.
The Naval Research Laboratory (NRL) intends to award a sole source purchase order to INTEGRATED DNA TECHNOLOGIES to furnish:
OGLIONUCLEOTIDE CARDS
The North American Industry Classification System Code (NAICS) for this requirement is 325413 with the size standard of 1250 . The Federal Supply Code (FSC) / Product Service Code (PSC) procurement is 6550 .
This purchase will be made utilizing Simplified Acquisition Procedures in accordance with:
Federal Acquisition Regulation (FAR) 12.201-1 for purchases not exceeding the simplified acquisition threshold of $350,000.
Interested parties may identify their interests and capability to respond to this requirement within fifteen (15) calendar days of the publication of this notice. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Information received will be considered solely for the purpose of determining whether or not to conduct a competitive procurement. A determination by the Government not to compete this proposed purchase order based upon response to this notice is solely within the discretion of the Government. No reimbursement for any cost connected with providing capability information will be provided.
The point of contact is: Richard Key , email: richard.a.key2.civ@us.navy.mil.
Please reference this Notice of Intent number on your correspondence and in the “Subject” line of your email.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
No documents available.
Lifecycle
- 1Version 1Special NoticeCurrent
Oglionucleotide Cards
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Requesting procurement of a high-throughput FDA approved molecular diagnostic testing system and reagents through a rental purchase agreement. Purchase order is requested to order additional specific products throughout the year necessary to perform rapid syndromic infectious disease diagnostic panels. | - | Market Research | 11/27/2026 |
BD Micro Reagents and Service | - | Awarded | Open |
CTX BD Micro Reagents and Service Contract | - | Awarded | Open |
NTX blood bank cost per test | - | Awarded | Open |
DLA – TS E&A, in conjunction with the United States Army Medical Materiel Center-Europe (USAMMCE), is conducting market research to support the recompete of its commercial laboratory supplies contract. The resulting contract will provide clinical laboratory reagents, test cartridges, calibrators, controls, and associated consumables that operate in conjunction with specific Government-owned laboratory analyzers and capital equipment (e.g., Abbott i-STAT, Siemens DCA 2000, and other point-of-care or automated platforms). The primary ordering activity and logistics hub is USAMMCE, servicing Department of Defense (DoD) medical treatment facilities and operational forces across the European Command (EUCOM) and possibly Central Command (CENTCOM) theaters. The follow-on ordering period is projected to commence on 15 January 2028. | - | Market Research | 10/30/2026 |
Additional Details
Solicitation Number
N0017326Q5252
Archive Date
Jun 25, 6026
Office Address
WASHINGTON, DC, 20375-5328